These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 31311970

  • 21. Comparison of Optical Coherence Tomography Angiography to Indocyanine Green Angiography and Slit Lamp Photography for Corneal Vascularization in an Animal Model.
    Stanzel TP, Devarajan K, Lwin NC, Yam GH, Schmetterer L, Mehta JS, Ang M.
    Sci Rep; 2018 Jul 31; 8(1):11493. PubMed ID: 30065317
    [Abstract] [Full Text] [Related]

  • 22. Quantitative Vascular Density Changes in Choriocapillaris Around CNV After Anti-VEGF Treatment: Dark Halo.
    Rispoli M, Savastano MC, Lumbroso B.
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec 01; 49(12):918-924. PubMed ID: 30566698
    [Abstract] [Full Text] [Related]

  • 23. The use of optical coherence tomography angiography to measure changes in iris vasculature after strabismus surgery.
    Vanlangenaeker L, Van Aerschot J, Putcuijps K, Dieltiëns M, Cassiman C.
    Strabismus; 2023 Dec 01; 31(4):244-252. PubMed ID: 37955328
    [Abstract] [Full Text] [Related]

  • 24. Characterization of Idiopathic Choroidal Neovascularization Using Fluorescein Angiography, Indocyanine Green Angiography, and Optical Coherence Tomography Angiography.
    Kumar A, Vohra R, Agrawal S, Chawla R, Azad SV, Venkatesh P, Sharma A.
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jul 01; 49(7):516-522. PubMed ID: 30021039
    [Abstract] [Full Text] [Related]

  • 25. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F, Schütze C, Burgmüller M, Vécsei-Marlovits PV, Weingessel B.
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug 01; 257(8):1581-1590. PubMed ID: 31037488
    [Abstract] [Full Text] [Related]

  • 26. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
    Romdhane K, Zola M, Matet A, Daruich A, Elalouf M, Behar-Cohen F, Mantel I.
    Br J Ophthalmol; 2020 Jul 01; 104(7):910-916. PubMed ID: 31615761
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
    Bo Q, Yan Q, Shen M, Song M, Sun M, Yu Y, Rosenfeld PJ, Wang F, Sun X.
    JAMA Ophthalmol; 2019 Jun 01; 137(6):642-650. PubMed ID: 30998817
    [Abstract] [Full Text] [Related]

  • 29. Reduced Vessel Density of the Choriocapillaris during Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.
    Hikichi T, Agarie M.
    Invest Ophthalmol Vis Sci; 2019 Mar 01; 60(4):1088-1095. PubMed ID: 30901385
    [Abstract] [Full Text] [Related]

  • 30. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, De Carlo TE, Waheed NK, Duker JS, Sarraf D.
    Am J Ophthalmol; 2015 Oct 01; 160(4):739-48.e2. PubMed ID: 26164826
    [Abstract] [Full Text] [Related]

  • 31. Choroidal Neovascularization Analyzed on Ultrahigh-Speed Swept-Source Optical Coherence Tomography Angiography Compared to Spectral-Domain Optical Coherence Tomography Angiography.
    Novais EA, Adhi M, Moult EM, Louzada RN, Cole ED, Husvogt L, Lee B, Dang S, Regatieri CV, Witkin AJ, Baumal CR, Hornegger J, Jayaraman V, Fujimoto JG, Duker JS, Waheed NK.
    Am J Ophthalmol; 2016 Apr 01; 164():80-8. PubMed ID: 26851725
    [Abstract] [Full Text] [Related]

  • 32. Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
    Skalet AH, Li Y, Lu CD, Jia Y, Lee B, Husvogt L, Maier A, Fujimoto JG, Thomas CR, Huang D.
    Ophthalmology; 2017 Feb 01; 124(2):197-204. PubMed ID: 27856029
    [Abstract] [Full Text] [Related]

  • 33. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.
    Ophthalmology; 2008 Sep 01; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. OCT Angiography Features of Neovascularization as Predictive Factors for Frequent Recurrence in Age-Related Macular Degeneration.
    Choi M, Kim SW, Yun C, Oh J.
    Am J Ophthalmol; 2020 May 01; 213():109-119. PubMed ID: 31954711
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
    Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S.
    Eur J Ophthalmol; 2008 May 01; 18(2):255-62. PubMed ID: 18320519
    [Abstract] [Full Text] [Related]

  • 39. Pigmented Iris Lesion on Anterior-Segment Swept-Source Optical Coherence Tomography.
    Vaidya S, Yaghy A, Shields CL.
    JAMA Ophthalmol; 2021 Jan 01; 139(1):e204079. PubMed ID: 33471034
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.